- Addex Reports Full Year 2022 Financial Results and Provides Corporate Update
- Addex Therapeutics to Release Full-Year 2022 Financial Results and Host Conference Call on March 30, 2023
- Addex Announces Upcoming Conferences it will participate for H1 2023
- Addex Regains Nasdaq Listing Compliance
- Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1
- Addex Provides Corporate Update and Financial Guidance
- Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration
- Addex Reports Q3 2022 Financial Results and Provides Corporate Update
- Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022
Addex Therapeutics Ltd (APE0:BER) closed at 0.905, 72.38% above the 52 week low of 0.525 set on Dec 23, 2022.
0.525Dec 23 20225.10Apr 27 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||23.61m USD|
Data delayed at least 15 minutes, as of Mar 30 2023 19:30 BST.